Evidence map›Paper›PMID 31360301›Full record

ArticleOncotarget2019

A novel curcumin analog inhibits canonical and non-canonical functions of telomerase through STAT3 and NF-κB inactivation in colorectal cancer cells.

Seyung S Chung, Pranabananda Dutta, Nathaniel Chard, Yong Wu, Qiao-Hong Chen, Guanglin Chen, Jaydutt Vadgama

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Targeting key transcriptional factor STAT3 in colorectal cancer.Molecular and cellular biochemistry · 2021
    Review
  18. Updated Review on the Role of Curcumin in Gastrointestinal Cancers.Advances in experimental medicine and biology · 2021
    Review
  19. Article
  20. Overcoming cancer therapeutic bottleneck by drug repurposing.Signal transduction and targeted therapy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Seyung S ChungDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA.
Pranabananda DuttaDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA.
Nathaniel ChardDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA.
Yong WuDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA.
Qiao-Hong ChenDepartment of Chemistry, California State University at Fresno, Fresno, California 93740, USA.
Guanglin ChenDepartment of Chemistry, California State University at Fresno, Fresno, California 93740, USA.
Jaydutt VadgamaDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA.
Charles R. Drew University of Medicine and Science · USCalifornia State University, Fresno · USUCLA Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles · US

Funding

Workshop for Junior Biostatisticians in Health ResearchU54MD007598 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI Jaydutt V. Vadgama · 2012 to 2026
$60.0M
Supporting African American Churches to Promote Cancer ScreeningU54CA143931 · NCI · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI VADGAMA, JAYDUTT V. · 2009 to 2022
$19.7M
Mechanisms behind hyperglycemia-associated breast cancer risk and progressionSC1CA200517 · NCI · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI WU, YONG · 2015 to 2018
$1.4M
Salinomycin Targets Colorectal Cancer by Inhibiting Cancer Stem Cells and TelomeraseSC2CA235066 · NCI · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI CHUNG, SEYUNG STEVEN · 2018 to 2019
$287k
NCI NIH HHS SC1 CA200517NCI NIH HHS SC2 CA235066NCI NIH HHS U54 CA143931NIMHD NIH HHS U54 MD007598
6 · The paper itself

Abstract

Curcumin is a biologically active polyphenol that exists in Indian spice turmeric. It has been reported that curcumin exerted anti-inflammatory, anti-oxidant and anti-cancer effects in numerous

Indexed as

cancer stem cellscolorectal cancercurcumin analogNF-κBSTAT3

Identifiers

PMID31360301
PMCPMC6642039
OpenAlexW2964617129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.